3

OWNERSHIP DOCUMENT

Company: Xenon Pharmaceuticals Inc.
Filed: September 27, 2016
Period of Report: September 27, 2016
Accession Number: 0001171843-16-012293

View Document ↗ View on SEC.gov ↗